William Blair analyst Alethia Young initiates coverage on Cytokinetics (NASDAQ: CYTK) with a Outperform rating.The analyst comments "We are initiating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage